首頁 > 市場調查報告書 > 製藥

感染疾病

膽道結石治療市場規模、佔有率和成長分析：按治療方法、產品類型、適應症、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

1973218

膽道結石治療市場規模、佔有率和成長分析：按治療方法、產品類型、適應症、最終用戶和地區分類－2026-2033年產業預測

Choledocholithiasis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Endoscopic Procedures, Surgical Procedures), By Product Type (Devices, Consumables), By Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球膽結石治療市場價值為4.655億美元，預計將從2025年的4.8971億美元成長到2033年的7.3462億美元。預測期（2026-2033年）的複合年成長率預計為5.2%。

全球膽道結石治療市場專注於透過先進的診斷和治療方法來管理膽管結石，其發展主要受人口結構變化和技術進步的驅動。由於膽管結石會引發膽管炎和胰臟炎等併發症，需要快速介入並造成巨大的醫療成本，因此該市場至關重要。從傳統外科手術到內視鏡逆行性造影(ERCP) 和雷射碎石術等微創技術的轉變，徹底改變了治療方式，縮短了患者的康復時間，並促進了門診手術的發展。尖端內視鏡技術的應用持續推動市場成長，使醫療機構能夠在提供有效治療的同時，最大限度地減少併發症和住院時間。人工智慧技術的進步進一步提高了診斷準確性，簡化了工作流程，並改善了患者的治療效果，最終為市場擴張和創新創造了巨大的機會。

全球膽道結石治療市場促進因素

全球膽道結石治療市場正在成長，這主要得益於內視鏡手術的日益普及，因為內視鏡手術為治療該疾病提供了微創選擇。醫療機構選擇這些技術的原因在於其許多優勢，例如降低病患併發症風險和縮短恢復時間。臨床醫生信心的增強、醫療設備的進步以及廣泛的培訓舉措，使得內視鏡治療在各種醫療機構中更容易獲得，從而促進了其更廣泛的應用。從傳統開放性手術向內視鏡技術的轉變，刺激了對專用器械和耗材的需求，推動了臨床指南的製定，並鼓勵了對手術技能的投資，從而增強了相關治療方法的市場。

全球膽道結石治療市場的限制因素

全球膽結石治療市場受到嚴格的報銷政策的顯著影響，這給醫療服務提供者和患者都帶來了經濟上的不確定性。由於醫療費用補償不足，醫療服務提供者往往會延後採用先進的治療技術，轉而選擇成本較低的治療方案。因此，患者可能會因為自付費用增加而放棄選擇性治療，最終導致手術數量減少。這種情況也阻礙了製造商投資新產品研發和擴大市場覆蓋範圍，減緩了創新解決方案的推出，並抑制了整體市場成長。

全球膽道結石治療市場趨勢

全球膽結石治療市場正經歷著向微創手術的顯著轉變，這主要受臨床偏好的改變所驅動，即選擇能夠提升患者舒適度並縮短康復時間的治療方案。醫院和專科醫療中心正在製定優先考慮內視鏡和經皮治療方法的籌資策略，促使醫療設備製造商更加重視器材的人體工學設計和相容性。此外，醫療保險公司和轉診醫生也越來越重視與縮短住院時間相關的治療效果，從而促進了製造商和醫療服務提供者之間的合作，以最佳化治療路徑。創新培訓計畫和旨在推廣先進技術的跨學科合作也進一步推動了這一發展趨勢。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Boston Scientific
Medtronic
Olympus Corporation
Cook Medical
Conmed Corporation
Johnson & Johnson
Stryker Corporation
B. Braun Melsungen AG
Abbott Laboratories
Intuitive Surgical
Hologic
Merit Medical Systems
Terumo Corporation
Amgen
Echosens
Siemens Healthineers
Ferring Pharmaceuticals
Inotek Pharmaceuticals
DePuy Synthes
Ethicon

結論與建議

簡介目錄

Product Code: SQMIG35F2022

Global Choledocholithiasis Treatment Market size was valued at USD 465.5 Million in 2024 and is poised to grow from USD 489.71 Million in 2025 to USD 734.62 Million by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).

The global choledocholithiasis treatment market focuses on managing bile duct stones through advanced diagnostics and therapies, driven by demographic shifts and technological advancements. This market is critical due to the potential complications of obstructing stones, such as cholangitis and pancreatitis, which necessitate timely intervention and significant healthcare costs. The evolution from traditional surgical methods to minimally invasive techniques, including endoscopic retrograde cholangiopancreatography and laser lithotripsy, has revolutionized treatment, reducing recovery times and encouraging outpatient procedures. The adoption of cutting-edge endoscopic technologies continues to spur growth, enabling healthcare providers to deliver effective care while minimizing complications and hospital stays. AI advancements are further enhancing diagnostic accuracy, streamlining workflows, and improving patient outcomes, ultimately creating significant opportunities for market expansion and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Choledocholithiasis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Choledocholithiasis Treatment Market Segments Analysis

Global choledocholithiasis treatment market is segmented by treatment type, product type, indication, end user and region. Based on treatment type, the market is segmented into Endoscopic Procedures, Surgical Procedures and Medical Management. Based on product type, the market is segmented into Devices and Consumables. Based on indication, the market is segmented into Primary Cause and Complications. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Choledocholithiasis Treatment Market

The Global Choledocholithiasis Treatment market is experiencing growth driven by the increasing preference for endoscopic procedures, which provide a less invasive option for managing this condition. Healthcare providers are choosing these techniques due to their associated benefits of reduced patient morbidity and quicker recovery times. Enhanced clinician confidence, advancements in device ergonomics, and extensive training initiatives have facilitated access to endoscopic treatments across various healthcare settings, promoting wider adoption. This transition from traditional open surgery to endoscopic methods is fueling the demand for specialized instruments and consumables, prompting the development of clinical guidelines and encouraging investments in procedural technologies, thereby bolstering the market for related therapies.

Restraints in the Global Choledocholithiasis Treatment Market

The global market for choledocholithiasis treatment is significantly impacted by restrictive reimbursement policies that create financial unpredictability for both healthcare providers and patients. Inadequate compensation for procedures can lead providers to postpone acquiring advanced therapeutic technologies, opting instead for less costly management options. Consequently, patients may be deterred from pursuing elective treatments due to increased out-of-pocket expenses, ultimately resulting in lower procedure volumes. This situation disincentivizes manufacturers from investing in new product development and expanding market offerings, resulting in a slowdown in the adoption of innovative solutions and hindering overall growth within the market.

Market Trends of the Global Choledocholithiasis Treatment Market

The Global Choledocholithiasis Treatment market is experiencing a significant trend towards minimally invasive procedures, as clinical preferences shift towards options that enhance patient comfort and expedite recovery times. Hospitals and specialty centers are tailoring their procurement strategies to prioritize endoscopic and percutaneous solutions, influencing device manufacturers to focus on ergonomics and compatibility in their instruments. Additionally, healthcare payers and referring clinicians are placing greater importance on outcomes associated with shorter hospital stays, leading to collaborative efforts between manufacturers and healthcare providers for optimized treatment pathways. This evolving landscape is further supported by innovative training programs and cross-disciplinary initiatives aimed at facilitating the widespread adoption of these advanced techniques.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Choledocholithiasis Treatment Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Endoscopic Procedures
- ERCP
- Endoscopic Sphincterotomy
Surgical Procedures
- Cholecystectomy
- Exploratory Laparotomy
Medical Management
- Medications
- Supportive Care

Global Choledocholithiasis Treatment Market Size by Product Type & CAGR (2026-2033)

Market Overview
Devices
- Biliary Stents
- Lithotripsy Devices
Consumables
- Surgical Supplies
- Diagnostic Kits

Global Choledocholithiasis Treatment Market Size by Indication & CAGR (2026-2033)

Market Overview
Primary Cause
- Gallstones
- Strictures
Complications
- Cholangitis
- Pancreatitis

Global Choledocholithiasis Treatment Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Specialty Clinics
Others

Global Choledocholithiasis Treatment Market Size & CAGR (2026-2033)

North America (Treatment Type, Product Type, Indication, End User)
- US
- Canada
Europe (Treatment Type, Product Type, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Type, Product Type, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Type, Product Type, Indication, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Type, Product Type, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boston Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intuitive Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Echosens
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inotek Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DePuy Synthes
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ethicon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments